Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study
NCT05946577 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2023-07-14
Summary
The aim of the AURACCO study is to evaluate the association between the onset of tinnitus and hearing loss in patients with locally advanced head and neck cancer treated by concomitant chemoradiotherapy or exclusive radiotherapy
Conditions
- Head Cancer
- Neck Cancer
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Florence HUGUET, MD, PhD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-31
- Primary Completion
- 2025-06-30
- Completion
- 2026-09-30
Countries
- France
Study Locations
More Related Trials
-
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
NCT05936034 ·Status: RECRUITING ·Phase: NA
-
Concurent Chemoradiotherapy in Head and Neck Cancers
NCT04780750 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03815903 ·Status: RECRUITING ·Phase: PHASE3
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
NCT04291209 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
NCT03225157 ·Status: COMPLETED
-
Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity
NCT02281006 ·Status: TERMINATED ·Phase: PHASE2
-
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00410826 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00625937 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia
NCT01598402 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03480672 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
NCT00498953 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
NCT06894459 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer
NCT06807697 ·Status: COMPLETED
-
Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer
NCT03194061 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
NCT06959082 ·Status: RECRUITING ·Phase: PHASE2
-
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
NCT00094081 ·Status: COMPLETED ·Phase: PHASE3
-
Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT02505672 ·Status: UNKNOWN
-
Hearing Impairment of Nasopharyngeal Carcinoma
NCT05330169 ·Status: COMPLETED
-
Induction Chemotherapy for Advanced Head and Neck Cancer
NCT00959387 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
NCT06957938 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers
NCT03193931 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT03129061 ·Status: COMPLETED ·Phase: PHASE1